The Food and Drug Administration (FDA) is warning that the medicine lamotrigine (Lamictal) for seizures and bipolar disorder can cause a rare but very serious reaction […]

Safety Announcement [6-25-2014] The U.S. Food and Drug Administration (FDA) is warning that certain over-the-counter (OTC) topical acne products can cause rare but serious and potentially […]

On This Page Date: September 18 – 20, 2023 Day1: Mon, Sep 18 12:00 PM – 6:00 PM ET Day2: Tue, Sep 19 9:00 AM – […]

[12-19-2017 ] The U.S. Food and Drug Administration (FDA) is requiring a new class warning and other safety measures for all gadolinium-based contrast agents (GBCAs) for […]

The U.S. Food and Drug Administration (FDA) is warning consumers about the risk of serious bleeding when using nonprescription, also known as over-the-counter or OTC, aspirin-containing […]

The U.S. Food and Drug Administration (FDA) is strengthening an existing label warning that non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs) increase the chance of a heart attack […]

[12-16-2016] Based on a U.S. Food and Drug Administration (FDA) review of a large clinical trial that we required the drug companies to conduct,1 we have […]

[04-26-2016] The U.S. Food and Drug Administration (FDA) is evaluating the results of a Danish study1 that conclude there is a possible increased risk of miscarriage […]

Safety Announcement [9-23-2013] The U.S. Food and Drug Administration (FDA) is requiring color changes to the writing on Duragesic (fentanyl) pain patches so they can be […]